ADRs seen at 10 mg dose typically used with L-dopa to treat Parkinson’s disease It has been brought to our attention that deprenyl has been associated with ADRs at the higher doses (10 mg/day) typically used when it is taken in conjunction with L-dopa for the treatment of Parkinson’s disease, although not at the low […]
![Follow Up to Knoll Interview—More on Deprenyl Dr. Knoll](https://lmreview.com/wp-content/uploads/2018/07/DrJKnoll_1-100x130.jpg)